Načítá se...
Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions
For nearly 30 years, patients with transfusional iron overload have depended on nightly deferoxamine infusions for iron chelation. Despite dramatic gains in life expectancy in the deferoxamine era for patients with transfusion-dependent anemias, the leading cause of death for young adults with thala...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The American Society of Hematology
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1895765/ https://ncbi.nlm.nih.gov/pubmed/16627763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-02-002394 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|